260 related articles for article (PubMed ID: 11102454)
1. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
Wang Q; Lu J; Yong EL
J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
[TBL] [Abstract][Full Text] [Related]
3. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
He B; Wilson EM
Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
[TBL] [Abstract][Full Text] [Related]
4. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
[TBL] [Abstract][Full Text] [Related]
6. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
Askew EB; Minges JT; Hnat AT; Wilson EM
Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.
Hodgson MC; Shen HC; Hollenberg AN; Balk SP
Mol Cancer Ther; 2008 Oct; 7(10):3187-94. PubMed ID: 18852122
[TBL] [Abstract][Full Text] [Related]
8. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.
Alen P; Claessens F; Verhoeven G; Rombauts W; Peeters B
Mol Cell Biol; 1999 Sep; 19(9):6085-97. PubMed ID: 10454556
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
[TBL] [Abstract][Full Text] [Related]
10. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
[TBL] [Abstract][Full Text] [Related]
11. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.
Bai S; He B; Wilson EM
Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378
[TBL] [Abstract][Full Text] [Related]
12. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor.
Haelens A; Tanner T; Denayer S; Callewaert L; Claessens F
Cancer Res; 2007 May; 67(9):4514-23. PubMed ID: 17483368
[TBL] [Abstract][Full Text] [Related]
13. Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions.
Duff J; McEwan IJ
Mol Endocrinol; 2005 Dec; 19(12):2943-54. PubMed ID: 16081517
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
Ikonen T; Palvimo JJ; Jänne OA
J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.
Gregory CW; Fei X; Ponguta LA; He B; Bill HM; French FS; Wilson EM
J Biol Chem; 2004 Feb; 279(8):7119-30. PubMed ID: 14662770
[TBL] [Abstract][Full Text] [Related]
17. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
[TBL] [Abstract][Full Text] [Related]
19. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.
Teyssier C; Belguise K; Galtier F; Chalbos D
J Biol Chem; 2001 Sep; 276(39):36361-9. PubMed ID: 11477071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
